Clinical safety of the selective PKC-β inhibitor, ruboxistaurin

Janet B. McGill, George L. King, Paul H. Berg, Karen L. Price, Keri A. Kles, Edward J. Bastyr, David L. Hyslop

Research output: Contribution to journalReview article

34 Scopus citations

Fingerprint Dive into the research topics of 'Clinical safety of the selective PKC-β inhibitor, ruboxistaurin'. Together they form a unique fingerprint.

Medicine & Life Sciences